Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
SYNLOGIC, INC. (SYBX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
10/04/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 4.7% stake in Synlogic, Inc. |
09/29/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/22/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
03/29/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/12/2019 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 6.4% stake in Synlogic, Inc. |
04/12/2018 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 8% stake in Synlogic, Inc. |
02/14/2018 |
SC 13D/A
| Sofinnova Venture Partners VIII, L.P. reports a 2.7% stake in Synlogic, Inc. |
02/01/2018 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 19.7% stake in Synlogic, Inc. |
01/26/2018 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 9.5% stake in Synlogic, Inc. |
09/07/2017 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 23.5% stake in Synlogic, Inc. |
05/16/2017 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 14.2% stake in Mirna Therapeutics, Inc. |
|
|